Bayer promotes workflow offerings at RSNA 2022

By staff writers

November 28, 2022 -- Bayer is highlighting new and expanded patient throughput and workflow features in its artificial intelligence (AI) portfolio at the RSNA meeting in Chicago.

Bayer is showcasing its next-generation CT technology, MEDRAD Centargo CT Injection system, which is pending clearance by the U.S. Food and Drug Administration (FDA), the company said.

It is also highlighting details on its recently launched Calantic SPARK program, an accelerator program for medical imaging app developers that supports them to bring new products to market. The program will initially focus on North America and Europe.

In addition, Bayer announced collaboration agreements with app developers Quantib, ClariPi, and EXINI Diagnostics which it hopes will expand the capacity of its medical imaging platform Calantic Digital Solutions. The new collaboration agreements broaden options for thoracic and neurological diseases on the Calantic platform by including tools to aid in breast and prostate imaging.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking